arrow_back Back to App

Limiting Health Innovation Funds for 2024

This bill proposes to cap the funding for health innovation, managed by the National Institutes of Health, at $496 million for the 2024 fiscal year. This means less money will be available for new medical research and development, potentially affecting the pace at which new treatments and medicines become available.
Key points
Reduced medical research funding: The bill limits funds for health innovation, which could slow down the development of new treatments.
Potential impact on drug availability: Lower investment in research might delay the emergence of new drugs and therapies for citizens.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_2001
Sponsor: Rep. Biggs, Andy [R-AZ-5]
Process start date: 2023-03-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health Innovation Account, CURES Act for fiscal year 2024.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_2001.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-29.

What are the main provisions?

Key points include:

  • Reduced medical research funding: The bill limits funds for health innovation, which could slow down the development of new treatments.
  • Potential impact on drug availability: Lower investment in research might delay the emergence of new drugs and therapies for citizens.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Biggs, Andy [R-AZ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health